2016
ONCOLOGISTS’ BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY
Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes K, Wheeler SB. ONCOLOGISTS’ BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY. International Journal Of Technology Assessment In Health Care 2016, 32: 355-361. PMID: 27958190, PMCID: PMC6526532, DOI: 10.1017/s026646231600060x.Peer-Reviewed Original ResearchConceptsAdjuvant chemotherapy decisionsBreast cancer patientsOncotype DXTreatment decisionsCancer patientsChemotherapy decisionsHormone receptor-positive breast cancer patientsClinical practiceReceptor-positive breast cancer patientsPositive breast cancer patientsOncotype DX useUnited States guidelinesProfiling testsEligible womenSurgical oncologistsCancer careClinical guidelinesModifiable barriersOncologistsMulti-level factorsPatientsThematic saturationPhone interviewsIntermediate scoresQualitative study
2006
Views of Potential Research Participants on Financial Conflicts of Interest: Barriers and Opportunities for Effective Disclosure
Weinfurt KP, Friedman JY, Allsbrook JS, Dinan MA, Hall MA, Sugarman J. Views of Potential Research Participants on Financial Conflicts of Interest: Barriers and Opportunities for Effective Disclosure. Journal Of General Internal Medicine 2006, 21: 901-906. PMID: 16918732, PMCID: PMC1831594, DOI: 10.1111/j.1525-1497.2006.00502.x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultDisclosureFocus GroupsHumansMiddle AgedQualitative ResearchResearch SubjectsResearch Support as TopicConceptsGroup of adultsPotential research participantsGroups of parentsFinancial interestsHeart failureHealthy childrenChronic illnessBrain tumorsHealthy adultsClinical researchConsent processAdultsGroup sessionsFocus group sessionsFocus group discussionsParticipantsFocus groupsGroupChildrenResearch participantsEffective disclosureGroup discussionsLeukemiaTumorsIllness